| Literature DB >> 28222667 |
Siying Zhou1,2, Sijie Zhang3, Hongyu Shen2,4, Wei Chen5, Hanzi Xu1,6, Xiu Chen2,4, Dawei Sun2, Shanliang Zhong7, Jianhua Zhao7, Jinhai Tang1,2,8.
Abstract
Curcumin, a major yellow pigment and spice in turmeric and curry, is a powerful anti-cancer agent. The anti-tumor activities of curcumin include inhibition of tumor proliferation, angiogenesis, invasion and metastasis, induction of tumor apoptosis, increase of chemotherapy sensitivity, and regulation of cell cycle and cancer stem cell, indicating that curcumin maybe a strong therapeutic potential through modulating various cancer progression. It has been reported that microRNAs as small noncoding RNA molecules are related to cancer progression, which can be regulated by curcumin. Dysregulated microRNAs play vital roles in tumor biology via regulating expressions of target genes and then influencing multiple cancer-related signaling pathways. In this review, we focused on the inhibition effect of curcumin on various cancer progression by regulating expression of multiple microRNAs. Curcumin-induced dysregulation of microRNAs may activate or inactivate a set of signaling pathways, such as Akt, Bcl-2, PTEN, p53, Notch, and Erbb signaling pathways. A better understanding of the relation between curcumin and microRNAs may provide a potential therapeutic target for various cancers.Entities:
Keywords: Curcumin; cancer; microRNA; signaling pathway; therapy
Mesh:
Substances:
Year: 2017 PMID: 28222667 DOI: 10.1177/1010428317691680
Source DB: PubMed Journal: Tumour Biol ISSN: 1010-4283